First FDA-approved AI platform for digital pathology that assists pathologists in cancer diagnosis. Uses deep learning algorithms trained on millions of pathology slides to detect prostate cancer, breast cancer, and lymph node metastases with superhuman accuracy. Provides automated tissue analysis, biomarker quantification, and diagnostic decision support. Integrates with existing laboratory workflows and digital microscopy systems to enhance pathologist productivity and diagnostic precision.
